Save your place

Sign in to WhoBought

Please try again later.

Ken Fisher's Lineage Cell Therapeutics, Inc. (LCTX) position

Not anymore: Ken Fisher fully exited LCTX in Q1 2024. The position peaked at an amount we cannot price in Q4 2023.
View full portfolio →
Value at exit
an amount we cannot price
Shares at exit
10K
Quarter-end price
No quarter-end price available

Average buy price is hidden here because at least one covered purchase quarter has no usable local mean price.

LCTX price vs Fisher's position

Dates
$1.05$1.1$1.15$1.2← Earlier —1 purchase
Average closing price · filing quarter
Price range · filing quarter

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2024 Exited −10K −100.0% 0 May 9, 2024
Q4 2023 New +10K 10K Mar 5, 2024
Data through Q1 2024 · filed May 9, 2024
2 grouped rows from 2 quarters

More Fisher positions

Common questions

Does Ken Fisher own LCTX?

Not currently. Ken Fisher fully exited LCTX in Q1 2024, and the complete history is above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Ken Fisher buy LCTX?

Ken Fisher first disclosed a LCTX position in Q4 2023; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Ken Fisher sell LCTX?

Yes. Ken Fisher reduced and then fully exited LCTX by Q1 2024; the reductions are in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of LCTX does Ken Fisher own?

None as of the latest filing: Ken Fisher has exited LCTX. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Ken Fisher pay for LCTX?

Ken Fisher began building the LCTX position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.